| Monica Rae Dziesinski, PA-C | |
|
3303 S 3rd Ave, Alpena, MI 49707-3307 | |
| (989) 358-3935 | |
| Not Available |
| Full Name | Monica Rae Dziesinski |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 3303 S 3rd Ave, Alpena, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992130926 | NPI | - | NPPES |
| 5601006794 | Other | MI | PERMANENT ID NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 5601006794 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alcona Citizens For Health Inc | 5991691958 | 52 |
News Archive
Should an abnormal heart rhythm detected by a smartwatch in otherwise healthy young adults be treated? Are the benefits of this new technology worth the risks? Where is the technology headed?
Two separate studies presented today at The International Liver Congress 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and Hepatitis C virus (HCV).
It is well known that smokers damage their health by directly inhaling cigarette smoke. Now, research published in BioMed Central's open access journal Environmental Health has shown that they are at additional risk from breathing environmental tobacco smoke, contrary to the prevailing assumption that such risks would be negligible in comparison to those incurred by actually smoking.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Rae Dziesinski, PA-C Po Box 655, Alpena, MI 49707-0655 Ph: (989) 358-3935 | Monica Rae Dziesinski, PA-C 3303 S 3rd Ave, Alpena, MI 49707-3307 Ph: (989) 358-3935 |
News Archive
Should an abnormal heart rhythm detected by a smartwatch in otherwise healthy young adults be treated? Are the benefits of this new technology worth the risks? Where is the technology headed?
Two separate studies presented today at The International Liver Congress 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and Hepatitis C virus (HCV).
It is well known that smokers damage their health by directly inhaling cigarette smoke. Now, research published in BioMed Central's open access journal Environmental Health has shown that they are at additional risk from breathing environmental tobacco smoke, contrary to the prevailing assumption that such risks would be negligible in comparison to those incurred by actually smoking.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 2 days ago
Jeffery Dale Wirgau, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 400 Johnson St, Alpena, MI 49707 Phone: 989-356-2161 | |
Jordan Bellmore, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 109 S 13th Ave, Alpena, MI 49707 Phone: 989-356-2400 | |
Jeffery A Kwiatkowski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 800-968-6866 Fax: 616-532-7230 | |
Mrs. Alexandria Mary Podczervinski, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-340-1211 Fax: 989-340-1214 | |
Steven C Hammond, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-356-4049 Fax: 989-356-6287 | |
Miss Sarah B. Stevens, P.A.C. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-356-4049 Fax: 989-358-3711 | |
Cynthia Marie Lamb, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-356-9333 |